
PR Newswire
Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 23, 202...
GOTHENBURG, Sweden, May 23, 2025 /PRNewswire/ -- The seventh edition of the competition focused on ...
GOTHENBURG, Sweden, May 22, 2025 /PRNewswire/ -- The seventh edition of the competition focused on ...
ATLANTA, May 23, 2025 /PRNewswire/ -- On May 22, 2025, SUNMI, a global leader in smart busine...
SHANGHAI, May 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"...
CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology compa...
This modular tool features 10+ accessories designed to meet diverse needs such as a jet fan, handhe...
ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy,...
QINGDAO, China, May 23, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronic...
HONG KONG, May 23, 2025 /PRNewswire/ -- OceanBase hosted a technical symposium during the annual IE...
HO CHI MINH CITY, Vietnam, May 23, 2025 /PRNewswire/ -- As Vietnam commemorates the 50th anniversar...
BEIJING, May 23, 2025 /PRNewswire/ -- A report from People's Daily: On May 23, at the opening ceremo...


ภาษาไทย
English